These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1869282)

  • 1. Potential innovations in scheduling of cancer chemotherapy.
    Norton L; Day R
    Important Adv Oncol; 1991; ():57-72. PubMed ID: 1869282
    [No Abstract]   [Full Text] [Related]  

  • 2. The optimal scheduling of two drugs with simple resistance for a problem in cancer chemotherapy.
    Murray JM
    IMA J Math Appl Med Biol; 1997 Dec; 14(4):283-303. PubMed ID: 9415996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Average relative dose intensity and the impact on design of clinical trials.
    Hryniuk WM
    Semin Oncol; 1987 Mar; 14(1):65-74. PubMed ID: 3823917
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination chemotherapy in advanced breast cancer. A report of the Working Party of the Multicentre Cancer Chemotherapy Group.
    Spittle MF; Bates TD; Kitchen G; Nicol NT; Wheeler T; Edelstyn G; MacRae KD; Ostrowski MJ
    Clin Oncol; 1980 Jun; 6(2):153-7. PubMed ID: 7408282
    [No Abstract]   [Full Text] [Related]  

  • 5. Conceptual basis for advances in the systemic drug therapy of breast cancer.
    Norton L
    Semin Oncol; 1997 Aug; 24(4 Suppl 11):S11-2-S11-12. PubMed ID: 9314292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Navelbine: a new step in cancer therapy?
    Armand JP; Marty M
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):41-5. PubMed ID: 2652319
    [No Abstract]   [Full Text] [Related]  

  • 7. [Dose intensity in cancer chemotherapy (including high dose chemotherapy)].
    Ariyoshi Y; Ogawa M
    Gan To Kagaku Ryoho; 1994 Dec; 21(16):2699-707. PubMed ID: 7993104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing chemotherapy for breast cancer: timing is everything.
    Hudis C
    J Clin Oncol; 2005 Aug; 23(24):5434-6. PubMed ID: 16110004
    [No Abstract]   [Full Text] [Related]  

  • 9. Alternation of chemotherapy and radiotherapy in cancer management. I. Summary of the Division of Cancer Treatment Workshop.
    Looney WB; Goldie JH; Little JB; Hopkins HA; Read EJ; Wittes R
    Cancer Treat Rep; 1985; 69(7-8):769-75. PubMed ID: 4016787
    [No Abstract]   [Full Text] [Related]  

  • 10. Preoperative chemotherapy for breast cancer.
    Buzdar AU
    Clin Adv Hematol Oncol; 2004 Apr; 2(4):212, 215. PubMed ID: 16163183
    [No Abstract]   [Full Text] [Related]  

  • 11. Performing chemotherapy in proper menstrual stage for maximal efficacy in breast cancer.
    Ling W; Yonggang LV
    Med Hypotheses; 2009 Sep; 73(3):460-1. PubMed ID: 19409715
    [No Abstract]   [Full Text] [Related]  

  • 12. [New agents in chemotherapy and new methods of their administration in the treatment of metastatic cancer of the breast].
    Cappelaere P
    Bull Cancer; 1989; 76(1):93-7. PubMed ID: 2713519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose and schedule as determinants of outcomes in chemotherapy for breast cancer.
    Budman DR
    Semin Oncol; 2004 Dec; 31(6 Suppl 15):3-9. PubMed ID: 15726532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ixabepilone (Ixempra) for breast cancer.
    Med Lett Drugs Ther; 2008 Jan; 50(1278):7-8. PubMed ID: 18219261
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypothesis: discontinuous chemotherapy for advanced breast cancer.
    Plotkin D; Waugh WJ
    Am J Clin Oncol; 1983 Jun; 6(3):375-9. PubMed ID: 6846254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-dense chemotherapy for primary breast cancer.
    Kümmel S; Rezai M; Kimmig R; Schmid P
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):75-81. PubMed ID: 17218856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interval between courses of high-dose chemotherapy with stem cell rescue: therapeutic hypotheses.
    Frei E; Richardson P; Avigan D; Bunnell C; Wheeler C; Elias A
    Bone Marrow Transplant; 1999 Nov; 24(9):939-45. PubMed ID: 10556951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].
    Pérez JE; Machiavelli M; Romero A; Leone BA; Rabinovich MG; Arévalo E
    Medicina (B Aires); 1982; 42(6 Pt 1):587-95. PubMed ID: 6897849
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvant chemotherapy--clinical trials and laboratory models.
    Wittes RE
    Cancer Treat Rep; 1986 Jan; 70(1):87-103. PubMed ID: 3510738
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic failure of antineoplastic agents. Extracellular and cellular causes].
    Hofsli E
    Tidsskr Nor Laegeforen; 1991 Jan; 111(1):37-40. PubMed ID: 2000585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.